Photo of Vicente Gonzalez
D United States House · District 34 · Texas On the 2026 ballot

Rep. Vicente Gonzalez

Compare
Total votes
2,818
all sessions
Attendance
96%
118 missed
Lower than 78% of chamber peers
With party
89%
of cast votes
Lower than 99% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 98% of chamber peers
Sponsored
716
bills & resolutions
Near the chamber average
Committees
3
assignments
716 bills and resolutions

Sponsored bills

Total
716
Primary
27
Co-sponsor
689
This page
716
matching current filters
Co-sponsor HR 2550
Passed · Delaware House · Co-sponsor
Protect America's Workforce Act

Maddy summaryThe Protect America's Workforce Act cancels an executive order issued on March 27, 2025, that excluded certain groups from federal labor-management relations programs, making it legally unenforceable. It also ensures that all collective bargaining agreements between federal agencies and labor unions, which were active as of March 26, 2025, remain fully effective until their agreed terms expire. This directly affects federal agencies, labor unions, and the employees covered by these agreements. The bill prevents federal funds from being used to implement the canceled executive order while preserving existing labor agreements.

Passed Dec 15, 2025 1 co-sponsor
Co-sponsor HR 6617
In committee · Delaware House · Co-sponsor
Keeping All Students Safe Act

Maddy summaryThe Keeping All Students Safe Act prohibits the use of unlawful seclusion and restraint in schools receiving federal funding, including physical restraint that restricts breathing or blood flow, chemical restraint not prescribed for medical treatment, and mechanical restraint. The bill requires schools to use less restrictive interventions first, mandates that staff using physical restraint be trained and certified through State-approved programs, and requires immediate parent notification after any restraint incident. States must develop plans to monitor compliance, collect and report data on restraint incidents (disaggregated by race, disability status, and school type), and implement positive behavioral interventions. The bill provides $40 million annually for five years to support states in implementing these requirements and improving school climate through evidence-based approaches.

In committee Dec 11, 2025 1 co-sponsor
Co-sponsor HR 6677
In committee · Delaware House · Co-sponsor
Professional Degree Access Restoration Act

Maddy summaryThis bill amends the Higher Education Act to extend the loan limits for graduate and professional students indefinitely. It removes the previous expiration date (June 30, 2026) for these limits, meaning graduate and professional students will continue to have access to the same federal loan amounts without a set end date. The key change modifies Section 455(a) by eliminating the sunset provision and updating the effective date language in the law. This directly affects students pursuing advanced degrees who rely on federal loans for tuition and living expenses. The bill makes a technical adjustment to existing student loan policy without creating new benefits or altering eligibility criteria.

In committee Dec 11, 2025 1 co-sponsor
Co-sponsor HR 6609
In committee · Delaware House · Co-sponsor
Pharmacists Fight Back in Medicare and Medicaid Act

Maddy summaryThis bill establishes new requirements for pharmacy benefit managers (PBMs) working with Medicare Part D prescription drug plans and Medicaid programs. It mandates that PBMs pay pharmacies a specific reimbursement amount based on drug acquisition costs plus a fixed fee, pass through manufacturer rebates directly to beneficiaries at the point of sale, and prohibits steering practices that direct patients to specific pharmacies. The bill applies to Medicare Part D plans and Medicaid managed care organizations beginning January 1, 2027, affecting how PBMs interact with pharmacies and handle drug rebates. Violations could result in criminal penalties of up to $1 million or 10 years in prison for willful noncompliance. The bill aims to increase transparency and fairness in pharmacy drug pricing for Medicare and Medicaid beneficiaries.

In committee Dec 11, 2025 1 co-sponsor
Co-sponsor HR 6575
In committee · Delaware House · Co-sponsor
CommonGround for Affordable Health Care Act

Maddy summaryHR 6575, the CommonGround for Affordable Health Care Act, extends enhanced premium tax credits for health insurance through 2026, directly benefiting millions of lower and middle-income Americans purchasing coverage through the ACA marketplace. The bill modifies income thresholds for premium subsidies, creating new income tiers that maintain or increase financial assistance for households earning up to 1,000% of the poverty level. It includes provisions to prevent fraud in health insurance exchanges by imposing civil penalties on agents and brokers who provide false information, and requires transparency in pharmacy benefit manager contracts to improve drug pricing accountability. The legislation also extends the annual open enrollment period for health insurance exchanges for the 2026 plan year, allowing more time for people to enroll or change coverage.

In committee Dec 10, 2025 1 co-sponsor
Co-sponsor HR 6511
In committee · Delaware House · Co-sponsor
Affordable Homeownership Access Act

Maddy summaryThe Affordable Homeownership Access Act exempts small property owners who provide direct financing (owner financing) from certain mortgage licensing requirements if they make no more than 24 loans per year for properties they own. It also amends federal definitions to exclude these owner financers from "mortgage originator" rules, requiring loans to be fully amortizing, have reasonable interest rate caps, and include buyer ability-to-pay assessments. The bill mandates a study by HUD and Treasury on owner financing usage - particularly for homes under $150,000 or 60% of local median value - to evaluate its potential to boost homeownership and wealth creation in underserved communities.

In committee Dec 9, 2025 1 co-sponsor
Co-sponsor HR 6501
In committee · Delaware House · Co-sponsor
Bipartisan Health Insurance Affordability Act

Maddy summaryThe Bipartisan Health Insurance Affordability Act extends and modifies premium tax credit rules to make health insurance more affordable for people with household incomes up to 700% of the poverty line, with specific provisions for different income tiers. The bill requires pharmacy benefit managers to pass through 100% of rebates to health plans, establishes transparency requirements for drug pricing, and creates mechanisms to prevent fraud in health insurance exchanges. It also extends the annual open enrollment period for 2026 and allows qualified Exchange enrollees to establish health savings accounts, with options to prepay annual premiums or direct part of their premium tax credit into a health savings account.

In committee Dec 9, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Delaware House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 5563
In committee · Delaware House · Co-sponsor
DRIVE-SAFE Act

Maddy summaryHR 5563, the DRIVE-SAFE Act, creates a structured apprenticeship program for commercial drivers under age 21. It requires employers to provide a two-phase training program: a 120-hour probationary period focused on basic driving skills (like traffic navigation and safety awareness), followed by a 280-hour period covering advanced tasks (such as pre-trip inspections and load management). During both phases, apprentices must operate vehicles equipped with automatic transmissions, collision mitigation systems, and video capture, and must be accompanied by an experienced driver (26+ years old with no recent accidents or violations). The bill does not change existing commercial driver’s license requirements and mandates employers to maintain records and provide remediation for preventable accidents or violations during training.

In committee Dec 1, 2025 1 co-sponsor
Co-sponsor HR 4312
In committee · Delaware House · Co-sponsor
SCORE Act

Student Compensation and Opportunity through Rights and Endorsements Act or the SCORE Act This bill provides a framework for the compensation of student athletes for the use of their name, image, or likeness (NIL). This includes addressing certain elements of the court approved agreement to settle the In re College Athlete NIL Litigation (i.e., House settlement ). Specifically, the bill statutorily prohibits institutions, conferences, or interstate intercollegiate athletic associations (e.g., the National Collegiate Athletic Association (NCAA)) from restricting the ability of a student athlete to enter an NIL agreement. The bill also requires institutions of higher education that generate $20 million or more in annual revenue from the institution's intercollegiate athletics activities to (1) provide counseling and medical benefits to student athletes, and (2) establish and maintain at least 16 varsity sports teams. Further, the bill authorizes interstate intercollegiate athletic associations to establish rules with respect to athletic eligibility, transfers, recruitment, and the disclosure of NIL agreements. Under the bill, student athletes may not be considered employees of an institution, conference, or interstate intercollegiate athletic association. The bill also preempts state laws with respect to compensation, payments, benefits, employment status, eligibility, and academic standards applicable to student athletes. Compliance with the provisions of this bill is considered lawful under federal and state antitrust laws.

In committee Dec 1, 2025 1 co-sponsor
Showing 61 to 70 of 716 bills
Previous 1 6 7 8 72 Next